Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Novaccess Global Inc (XSNX)

Novaccess Global Inc (XSNX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 9,171
  • Shares Outstanding, K 14,329
  • Annual Sales, $ 0 K
  • Annual Income, $ -6,770 K
  • 60-Month Beta 1.66
  • Price/Sales -11.05
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade XSNX with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.19
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 08/20/21
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.4000 +60.00%
on 09/13/21
0.6500 -1.54%
on 08/27/21
+0.1100 (+20.75%)
since 08/17/21
3-Month
0.4000 +60.00%
on 09/13/21
0.9600 -33.33%
on 07/19/21
+0.0600 (+10.34%)
since 06/17/21
52-Week
0.2510 +154.98%
on 11/09/20
0.9700 -34.02%
on 06/14/21
-0.1600 (-20.00%)
since 09/17/20

Most Recent Stories

More News
NovAccess Global, Inc. CEO Interviewed On MoneyTV

CLEVELAND, OH / ACCESSWIRE / September 15, 2021 / NovAccess Global, Inc. (OTC PINK:XSNX) announced Dr. Dwain Irvin's interview on MoneyTV aired on September 11, 2021.

XSNX : 0.6400 (+47.81%)
This Week on MoneyTV with Donald Baillargeon, 9/10

HOLLYWOOD, CA / ACCESSWIRE / September 10, 2021 / Cancer treatment breakthroughs, self-driving cars, restaurant hypocrisy; this week on MoneyTV with Donald Baillargeon

XNDA : 0.0200 (-95.56%)
XSNX : 0.6400 (+47.81%)
NovAccess Global, Inc. to Present at the Prestigious Society for Brain Mapping and Therapeutics 2021 World Congress

CLEVELAND, OH / ACCESSWIRE / July 8, 2021 / NovAccess Global, Inc. (OTC PINK:XSNX) announced it has been invited to present at the Society for Brain Mapping and Therapeutics (SBMT) 18th World Congress,...

XSNX : 0.6400 (+47.81%)
NovAccess Global, Inc. Announces Successful Completion of Pre-IND Meeting with FDA

CLEVELAND, OH / ACCESSWIRE / June 29, 2021 / NovAccess Global Inc. (OTC PINK:XSNX) announced today that it received a productive response from the U.S. Food and Drug Administration (FDA) on its pre-investigational...

XSNX : 0.6400 (+47.81%)
NovAccess Global Readies for Development of Novel Immunotherapies for Brain Tumor Patients with pre-IND meeting scheduled with the FDA and Files Form 10-K for Fiscal 2020 and Form 10-Q for FQ1/FQ2, 2021

CLEVELAND, OH / ACCESSWIRE / June 8, 2021 / NovAccess Global, Inc. (OTC PINK:XSNX) (the 'Company' or 'NovAccess'), a cancer therapeutics company with operations in biotechnology, is pleased to announce...

XSNX : 0.6400 (+47.81%)
NovAccess Global Secures Worldwide Rights to Approved Patent

Provides advancement for its immunotherapy technology against brain tumors into human clinical trials

XSNX : 0.6400 (+47.81%)
NovAccess Global Enhances Scientific Advisory Board with Distinguished Industry Experts and adds Chief Financial Officer

NovAccess Global Enhances Scientific Advisory Board with Distinguished Industry Experts and adds Chief Financial Officer

XSNX : 0.6400 (+47.81%)
NovAccess Global Appoints Dwain Irvin, Ph.D., MPH as New Chief Executive Officer

Leadership by world-renown cancer researcher signals commitment to driving current and forthcoming biomedical opportunities

XSNX : 0.6400 (+47.81%)
NovAccess Global Acquires StemVax Therapeutics from Innovest Global

Acquisition Launches NovAccess Shift, Focusing on Diagnostics and Therapeutics in Cancer

XSNX : 0.6400 (+47.81%)
IVST : 0.0499 (-14.70%)
XSNXD : 0.8000 (+26.48%)
XsunX, Inc. Changes Name to NovAccess Global Inc.

Name Change, Reverse Stock Split, and Other Planned Corporate Actions Highlight Focus on Enhancing Shareholder Value

IVST : 0.0499 (-14.70%)
XSNX : 0.6400 (+47.81%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Key Turning Points

3rd Resistance Point 0.9377
2nd Resistance Point 0.7913
1st Resistance Point 0.7157
Last Price 0.6400
1st Support Level 0.4937
2nd Support Level 0.3473
3rd Support Level 0.2717

See More

52-Week High 0.9700
Fibonacci 61.8% 0.6953
Last Price 0.6400
Fibonacci 50% 0.6105
Fibonacci 38.2% 0.5257
52-Week Low 0.2510

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar